MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$9,644K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from issuance of common...
Stock-based compensation
Prepaid expenses and other curre...
Others
Negative Cash Flow Breakdown
Net loss
Accrued expenses
Accounts payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-8,491
-9,589
-10,937
-8,692
Stock-based compensation
815
722
503
784
Impairment charge on investment in equity securities
-
-
0
0
Depreciation
4
4
4
4
Loss on disposal of assets
-
-
0
0
Prepaid materials
0
-68
-62
-332
Prepaid expenses and other current assets
-34
699
548
-495
Other assets
0
-711
-343
329
Accounts payable
-593
-1,724
761
1,522
Accrued expenses
-1,427
1,500
-682
-211
Payroll liabilities
29
-615
433
71
Other current liabilities
-15
41
-478
19
Net cash used in operating activities
-9,644
-9,581
-10,539
-6,005
Purchases of property and equipment
0
0
7
7
Net cash used in investing activities
0
0
-7
-7
Proceeds from issuance of common stock and warrants
4,500
-
-
-
Offering costs for common stock and warrant issuance
501
-
-
-
Proceeds from exercise of warrants
-
-
0
0
Proceeds from issuance of common stock under the atm program, net of issuance costs
21
-
-
-
Net cash provided by financing activities
4,020
0
0
0
Net decrease in cash, cash equivalents and restricted cash
-5,624
-9,581
-10,546
-6,012
Cash, cash equivalents and restricted cash, beginning balance
31,828
41,409
51,955
71,194
Cash, cash equivalents and restricted cash, ending balance
26,204
-
-
-
Cash and cash equivalents
26,094
-
-
-
Restricted cash
110
-
-
-
Total cash, cash equivalents and restricted cash
26,204
31,828
41,409
51,955
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
common stock and...
$4,500K
Proceeds from issuance of
common stock under the...
$21K
Net cash provided by
financing activities
$4,020K
Canceled cashflow
$501K
Net decrease in
cash, cash...
-$5,624K
(57.48%↑ Y/Y)
Canceled cashflow
$4,020K
Stock-based compensation
$815K
(-40.03%↓ Y/Y)
Prepaid expenses and
other current assets
-$34K
(62.22%↑ Y/Y)
Payroll liabilities
$29K
(103.59%↑ Y/Y)
Depreciation
$4K
(-50.00%↓ Y/Y)
Offering costs for common
stock and warrant...
$501K
Net cash used in
operating activities
-$9,644K
(27.04%↑ Y/Y)
Canceled cashflow
$882K
Net loss
-$8,491K
(43.92%↑ Y/Y)
Accrued expenses
-$1,427K
(-211.40%↓ Y/Y)
Accounts payable
-$593K
(-144.55%↓ Y/Y)
Other current
liabilities
-$15K
(-130.61%↓ Y/Y)
Buy us a coffee
ATOSSA THERAPEUTICS, INC. (ATOS)
ATOSSA THERAPEUTICS, INC. (ATOS)